Placeholder Image

字幕表 動画を再生する

  • RESOURCES

  • RESOURCES AND

  • RESOURCES AND AS

  • RESOURCES AND AS OF

  • RESOURCES AND AS OF TODAY

  • RESOURCES AND AS OF TODAY CORONAVIRUS

  • RESOURCES AND AS OF TODAY CORONAVIRUS HAS

  • RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN

  • RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO

  • RESOURCES AND AS OF TODAY CORONAVIRUS HAS BEEN TO 18

  • CORONAVIRUS HAS BEEN TO 18

  • CORONAVIRUS HAS BEEN TO 18 COUNTRIES.

  • COUNTRIES.

  • COUNTRIES. GEORGIA4@

  • COUNTRIES. GEORGIA4@ IS

  • COUNTRIES. GEORGIA4@ IS A

  • COUNTRIES. GEORGIA4@ IS A PART

  • COUNTRIES. GEORGIA4@ IS A PART OF

  • COUNTRIES. GEORGIA4@ IS A PART OF THE

  • COUNTRIES. GEORGIA4@ IS A PART OF THE RACE

  • COUNTRIES. GEORGIA4@ IS A PART OF THE RACEO

  • GEORGIA4@ IS A PART OF THE RACEO

  • GEORGIA4@ IS A PART OF THE RACEO DEVELOP

  • GEORGIA4@ IS A PART OF THE RACEO DEVELOP A

  • GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE

  • GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND

  • GEORGIA4@ IS A PART OF THE RACEO DEVELOP A VACCINE AND DEKALB

  • DEVELOP A VACCINE AND DEKALB

  • DEVELOP A VACCINE AND DEKALB COUNTY

  • DEVELOP A VACCINE AND DEKALB COUNTY COMPANY

  • DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES

  • DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT

  • DEVELOP A VACCINE AND DEKALB COUNTY COMPANY BELIEVES IT HAS

  • COUNTY COMPANY BELIEVES IT HAS

  • COUNTY COMPANY BELIEVES IT HAS AN

  • COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE

  • COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE

  • COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT

  • COUNTY COMPANY BELIEVES IT HAS AN ADVANTAGE BECAUSE IT HAS

  • AN ADVANTAGE BECAUSE IT HAS

  • AN ADVANTAGE BECAUSE IT HAS QUITE

  • AN ADVANTAGE BECAUSE IT HAS QUITE A

  • AN ADVANTAGE BECAUSE IT HAS QUITE A LONG

  • AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK

  • AN ADVANTAGE BECAUSE IT HAS QUITE A LONG TRACK RECORD.

  • QUITE A LONG TRACK RECORD.

  • QUITE A LONG TRACK RECORD. >>

  • QUITE A LONG TRACK RECORD. >> WE

  • QUITE A LONG TRACK RECORD. >> WE WANTED

  • QUITE A LONG TRACK RECORD. >> WE WANTED TO

  • QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN

  • QUITE A LONG TRACK RECORD. >> WE WANTED TO LEARN MORE

  • >> WE WANTED TO LEARN MORE

  • >> WE WANTED TO LEARN MORE ABOUT

  • >> WE WANTED TO LEARN MORE ABOUT THE

  • >> WE WANTED TO LEARN MORE ABOUT THE PROCESS

  • >> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND

  • >> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE

  • >> WE WANTED TO LEARN MORE ABOUT THE PROCESS AND JOE HENKE

  • ABOUT THE PROCESS AND JOE HENKE

  • ABOUT THE PROCESS AND JOE HENKE STOPPED

  • ABOUT THE PROCESS AND JOE HENKE STOPPED BY

  • ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR

  • ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A

  • ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB

  • ABOUT THE PROCESS AND JOE HENKE STOPPED BY FOR A LAB REPORT.

  • STOPPED BY FOR A LAB REPORT.

  • STOPPED BY FOR A LAB REPORT. >>

  • STOPPED BY FOR A LAB REPORT. >> Reporter:

  • STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY

  • STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A

  • STOPPED BY FOR A LAB REPORT. >> Reporter: CURRENTLY A RISK

  • >> Reporter: CURRENTLY A RISK

  • >> Reporter: CURRENTLY A RISK OF

  • >> Reporter: CURRENTLY A RISK OF VACCINES

  • >> Reporter: CURRENTLY A RISK OF VACCINES FOR

  • >> Reporter: CURRENTLY A RISK OF VACCINES FOR THE

  • >> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS

  • >> Reporter: CURRENTLY A RISK OF VACCINES FOR THE VIRUS IS

  • OF VACCINES FOR THE VIRUS IS

  • OF VACCINES FOR THE VIRUS IS BEING

  • OF VACCINES FOR THE VIRUS IS BEING TESTED

  • OF VACCINES FOR THE VIRUS IS BEING TESTED OR

  • OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY

  • OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO

  • OF VACCINES FOR THE VIRUS IS BEING TESTED OR READY TO BE

  • BEING TESTED OR READY TO BE

  • BEING TESTED OR READY TO BE TESTED

  • BEING TESTED OR READY TO BE TESTED AND

  • BEING TESTED OR READY TO BE TESTED AND SOME4@

  • BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE

  • BEING TESTED OR READY TO BE TESTED AND SOME4@ ARE VIRUSES

  • TESTED AND SOME4@ ARE VIRUSES

  • TESTED AND SOME4@ ARE VIRUSES SIMILAR

  • TESTED AND SOME4@ ARE VIRUSES SIMILAR TO

  • TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS

  • TESTED AND SOME4@ ARE VIRUSES SIMILAR TO CORONAVIRUS WHICH

  • SIMILAR TO CORONAVIRUS WHICH

  • SIMILAR TO CORONAVIRUS WHICH COULD

  • SIMILAR TO CORONAVIRUS WHICH COULD SPEED

  • SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP

  • SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE

  • SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS

  • SIMILAR TO CORONAVIRUS WHICH COULD SPEED UP THE PROCESS AND

  • COULD SPEED UP THE PROCESS AND

  • COULD SPEED UP THE PROCESS AND SOME

  • COULD SPEED UP THE PROCESS AND SOME WHO

  • COULD SPEED UP THE PROCESS AND SOME WHO HAS

  • COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX

  • COULD SPEED UP THE PROCESS AND SOME WHO HAS SIX EXISTING

  • SOME WHO HAS SIX EXISTING

  • SOME WHO HAS SIX EXISTING RELATIONSHIPS

  • SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH

  • SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH

  • SOME WHO HAS SIX EXISTING RELATIONSHIPS WITH HEALTH 4@

  • RELATIONSHIPS WITH HEALTH 4@

  • RELATIONSHIPS WITH HEALTH 4@ OFFICIALS

  • RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T

  • RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@

  • RELATIONSHIPS WITH HEALTH 4@ OFFICIALS DOESN'T HURT4@ EITHER

  • OFFICIALS DOESN'T HURT4@ EITHER

  • OFFICIALS DOESN'T HURT4@ EITHER >>

  • OFFICIALS DOESN'T HURT4@ EITHER >> Reporter:

  • OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS

  • OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE

  • OFFICIALS DOESN'T HURT4@ EITHER >> Reporter: SCIENTISTS LIKE RV

  • >> Reporter: SCIENTISTS LIKE RV

  • >> Reporter: SCIENTISTS LIKE RV INFECT

  • >> Reporter: SCIENTISTS LIKE RV INFECT CELLS

  • >> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN

  • >> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES

  • >> Reporter: SCIENTISTS LIKE RV INFECT CELLS IN VIRUSES THEY

  • INFECT CELLS IN VIRUSES THEY

  • INFECT CELLS IN VIRUSES THEY ARE

  • INFECT CELLS IN VIRUSES THEY ARE SETTING

  • INFECT CELLS IN VIRUSES THEY ARE SETTING AND

  • INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE

  • INFECT CELLS IN VIRUSES THEY ARE SETTING AND USE THEIR

  • ARE SETTING AND USE THEIR

  • ARE SETTING AND USE THEIR FINDINGS

  • ARE SETTING AND USE THEIR FINDINGS AS4@

  • ARE SETTING AND USE THEIR FINDINGS AS4@ THEY

  • ARE SETTING AND USE THEIR FINDINGS AS4@ THEY DEVELOP

  • FINDINGS AS4@ THEY DEVELOP

  • FINDINGS AS4@ THEY DEVELOP VACCINES.

  • VACCINES.

  • VACCINES. THEY

  • VACCINES. THEY USE

  • VACCINES. THEY USE AN

  • VACCINES. THEY USE AN APPROACH

  • VACCINES. THEY USE AN APPROACH THAT

  • VACCINES. THEY USE AN APPROACH THAT THE

  • THEY USE AN APPROACH THAT THE

  • THEY USE AN APPROACH THAT THE CEO

  • THEY USE AN APPROACH THAT THE CEO SAYS

  • THEY USE AN APPROACH THAT THE CEO SAYS IT

  • THEY USE AN APPROACH THAT THE CEO SAYS IT IS

  • THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT

  • THEY USE AN APPROACH THAT THE CEO SAYS IT IS EFFICIENT IN

  • CEO SAYS IT IS EFFICIENT IN

  • CEO SAYS IT IS EFFICIENT IN CREATING

  • CEO SAYS IT IS EFFICIENT IN CREATING A

  • CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE

  • CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO

  • CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE

  • CEO SAYS IT IS EFFICIENT IN CREATING A VACCINE TO BE TESTED

  • CREATING A VACCINE TO BE TESTED

  • CREATING A VACCINE TO BE TESTED AND

  • CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE

  • CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS

  • CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT

  • CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES

  • CREATING A VACCINE TO BE TESTED AND 4@EFFECTIVE AS IT MAKES A

  • AND 4@EFFECTIVE AS IT MAKES A

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S A

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S A SINGLE

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S A SINGLE DOSE

  • AND 4@EFFECTIVE AS IT MAKES A VACCINE THAT'S A SINGLE DOSE AND

  • VACCINE THAT'S A SINGLE DOSE AND

  • VACCINE THAT'S A SINGLE DOSE AND SET

  • VACCINE THAT'S A SINGLE DOSE AND SET OF

  • VACCINE THAT'S A SINGLE DOSE AND SET OF MULTIPLE

  • VACCINE THAT'S A SINGLE DOSE AND SET OF MULTIPLE DOSES.

  • SET OF MULTIPLE DOSES.

  • SET OF MULTIPLE DOSES. GENERALLY

  • SET OF MULTIPLE DOSES. GENERALLY THEY

  • SET OF MULTIPLE DOSES. GENERALLY THEY CAN

  • SET OF MULTIPLE DOSES. GENERALLY THEY CAN CREATE

  • SET OF MULTIPLE DOSES. GENERALLY THEY CAN CREATE A

  • GENERALLY THEY CAN CREATE A

  • GENERALLY THEY CAN CREATE A BASIS

  • GENERALLY THEY CAN CREATE A BASIS FOR

  • GENERALLY THEY CAN CREATE A BASIS FOR A

  • GENERALLY THEY CAN CREATE A BASIS FOR A VACCINE

  • GENERALLY THEY CAN CREATE A BASIS FOR A VACCINE WITHIN

  • BASIS FOR A VACCINE WITHIN

  • BASIS FOR A VACCINE WITHIN THREE

  • BASIS FOR A VACCINE WITHIN THREE MONTHS

  • BASIS FOR A VACCINE WITHIN THREE MONTHS AND

  • BASIS FOR A VACCINE WITHIN THREE MONTHS AND BEGIN

  • BASIS FOR A VACCINE WITHIN THREE MONTHS AND BEGIN ANIMAL

  • THREE MONTHS AND BEGIN ANIMAL

  • THREE MONTHS AND BEGIN ANIMAL TESTING.

  • TESTING.

  • TESTING. >>

  • TESTING. >> GOING

  • TESTING. >> GOING BEYOND

  • TESTING. >> GOING BEYOND THAT

  • TESTING. >> GOING BEYOND THAT IN

  • TESTING. >> GOING BEYOND THAT IN THE

  • >> GOING BEYOND THAT IN THE

  • >> GOING BEYOND THAT IN THE CLINICAL

  • >> GOING BEYOND THAT IN THE CLINICAL IS

  • >> GOING BEYOND THAT IN THE CLINICAL IS A

  • >> GOING BEYOND THAT IN THE CLINICAL IS A FUNCTION

  • >> GOING BEYOND THAT IN THE CLINICAL IS A FUNCTION OF

  • >> GOING BEYOND THAT IN THE CLINICAL IS A FUNCTION OF WHAT

  • CLINICAL IS A FUNCTION OF WHAT

  • CLINICAL IS A FUNCTION OF WHAT REGULATORY

  • CLINICAL IS A FUNCTION OF WHAT REGULATORY AUTHORITIES

  • REGULATORY AUTHORITIES

  • REGULATORY AUTHORITIES DETERMINE

  • REGULATORY AUTHORITIES DETERMINE WHAT

  • REGULATORY AUTHORITIES DETERMINE WHAT IS

  • REGULATORY AUTHORITIES DETERMINE WHAT IS APPROPRIATE

  • DETERMINE WHAT IS APPROPRIATE

  • DETERMINE WHAT IS APPROPRIATE PROTOCOL

  • DETERMINE WHAT IS APPROPRIATE PROTOCOL TO

  • DETERMINE WHAT IS APPROPRIATE PROTOCOL TO FOLLOW

  • DETERMINE WHAT IS APPROPRIATE PROTOCOL TO FOLLOW AND

  • PROTOCOL TO FOLLOW AND

  • PROTOCOL TO FOLLOW AND DEPENDING

  • PROTOCOL TO FOLLOW AND DEPENDING ON

  • PROTOCOL TO FOLLOW AND DEPENDING ON THAT

  • PROTOCOL TO FOLLOW AND DEPENDING ON THAT THAT

  • PROTOCOL TO FOLLOW AND DEPENDING ON THAT THAT WILL

  • DEPENDING ON THAT THAT WILL

  • DEPENDING ON THAT THAT WILL DETERMINE

  • DEPENDING ON THAT THAT WILL DETERMINE HOW

  • DEPENDING ON THAT THAT WILL DETERMINE HOW IT

  • DEPENDING ON THAT THAT WILL DETERMINE HOW IT WILL

  • DEPENDING ON THAT THAT WILL DETERMINE HOW IT WILL GO

  • DEPENDING ON THAT THAT WILL DETERMINE HOW IT WILL GO TO

  • DETERMINE HOW IT WILL GO TO

  • DETERMINE HOW IT WILL GO TO HUMANS.

  • HUMANS.

  • HUMANS. >>

  • HUMANS. >> 4@THEY

  • HUMANS. >> 4@THEY HAVE

  • HUMANS. >> 4@THEY HAVE VACCINES

  • HUMANS. >> 4@THEY HAVE VACCINES FOR

  • HUMANS. >> 4@THEY HAVE VACCINES FOR OTH

  • >> 4@THEY HAVE VACCINES FOR OTH

  • >> 4@THEY HAVE VACCINES FOR OTH VIRUSES

  • >> 4@THEY HAVE VACCINES FOR OTH VIRUSES AND

  • >> 4@THEY HAVE VACCINES FOR OTH VIRUSES AND VACCINES

  • >> 4@THEY HAVE VACCINES FOR OTH VIRUSES AND VACCINES ENTRY

  • VIRUSES AND VACCINES ENTRY

  • VIRUSES AND VACCINES ENTRY CLINICAL

  • VIRUSES AND VACCINES ENTRY CLINICAL CLOUD

  • VIRUSES AND VACCINES ENTRY CLINICAL CLOUD TILES.

  • CLINICAL CLOUD TILES.

  • CLINICAL CLOUD TILES. WITH

  • CLINICAL CLOUD TILES. WITH THE

  • CLINICAL CLOUD TILES. WITH THE CORONAVIRUS

  • CLINICAL CLOUD TILES. WITH THE CORONAVIRUS TIME

  • CLINICAL CLOUD TILES. WITH THE CORONAVIRUS TIME IS

  • CLINICAL CLOUD TILES. WITH THE CORONAVIRUS TIME IS OF

  • WITH THE CORONAVIRUS TIME IS OF

  • WITH THE CORONAVIRUS TIME IS OF THE

  • WITH THE CORONAVIRUS TIME IS OF THE ESSENCE

  • WITH THE CORONAVIRUS TIME IS OF THE ESSENCE AND

  • WITH THE CORONAVIRUS TIME IS OF THE ESSENCE AND THEY

  • WITH THE CORONAVIRUS TIME IS OF THE ESSENCE AND THEY CAN

  • WITH THE CORONAVIRUS TIME IS OF THE ESSENCE AND THEY CAN USE

  • THE ESSENCE AND THEY CAN USE

  • THE ESSENCE AND THEY CAN USE RESEARCH.

  • RESEARCH.

  • RESEARCH. >>

  • RESEARCH. >> THIS

  • RESEARCH. >> THIS VIRUS

  • RESEARCH. >> THIS VIRUS IS

  • RESEARCH. >> THIS VIRUS IS SIMILAR

  • RESEARCH. >> THIS VIRUS IS SIMILAR TO

  • >> THIS VIRUS IS SIMILAR TO

  • >> THIS VIRUS IS SIMILAR TO SARS

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND WE

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND WE CAN

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND WE CAN BUILD

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND WE CAN BUILD UPON

  • >> THIS VIRUS IS SIMILAR TO SARS 4@AND WE CAN BUILD UPON TH

  • SARS 4@AND WE CAN BUILD UPON TH

  • SARS 4@AND WE CAN BUILD UPON TH FOUNDATION

  • SARS 4@AND WE CAN BUILD UPON TH FOUNDATION OF

  • SARS 4@AND WE CAN BUILD UPON TH FOUNDATION OF LITERATURE

  • SARS 4@AND WE CAN BUILD UPON TH FOUNDATION OF LITERATURE THAT

  • FOUNDATION OF LITERATURE THAT

  • FOUNDATION OF LITERATURE THAT EXISTS

  • FOUNDATION OF LITERATURE THAT EXISTS PERTAINING

  • FOUNDATION OF LITERATURE THAT EXISTS PERTAINING TO

  • EXISTS PERTAINING TO

  • EXISTS PERTAINING TO DEVELOPMENT

  • EXISTS PERTAINING TO DEVELOPMENT OF

  • EXISTS PERTAINING TO DEVELOPMENT OF THE

  • EXISTS PERTAINING TO DEVELOPMENT OF THE SARS

  • EXISTS PERTAINING TO DEVELOPMENT OF THE SARS VACCINE

  • DEVELOPMENT OF THE SARS VACCINE

  • DEVELOPMENT OF THE SARS VACCINE AND

  • DEVELOPMENT OF THE SARS VACCINE AND APPLY

  • DEVELOPMENT OF THE SARS VACCINE AND APPLY IT

  • DEVELOPMENT OF THE SARS VACCINE AND APPLY IT FOR

  • DEVELOPMENT OF THE SARS VACCINE AND APPLY IT FOR THIS

  • DEVELOPMENT OF THE SARS VACCINE AND APPLY IT FOR THIS OUTBREAK.

  • AND APPLY IT FOR THIS OUTBREAK.

  • AND APPLY IT FOR THIS OUTBREAK. >>4@

  • AND APPLY IT FOR THIS OUTBREAK. >>4@ WORKING

  • AND APPLY IT FOR THIS OUTBREAK. >>4@ WORKING ALONGSIDE

  • AND APPLY IT FOR THIS OUTBREAK. >>4@ WORKING ALONGSIDE THEM

  • AND APPLY IT FOR THIS OUTBREAK. >>4@ WORKING ALONGSIDE THEM IS

  • >>4@ WORKING ALONGSIDE THEM IS

  • >>4@ WORKING ALONGSIDE THEM IS BRAVO

  • >>4@ WORKING ALONGSIDE THEM IS BRAVO MAX

  • >>4@ WORKING ALONGSIDE THEM IS BRAVO MAX ARE

  • >>4@ WORKING ALONGSIDE THEM IS BRAVO MAX ARE WUHAN

  • >>4@ WORKING ALONGSIDE THEM IS BRAVO MAX ARE WUHAN VACCINE

  • BRAVO MAX ARE WUHAN VACCINE

  • BRAVO MAX ARE WUHAN VACCINE DEVELOPER

  • BRAVO MAX ARE WUHAN VACCINE DEVELOPER IN

  • BRAVO MAX ARE WUHAN VACCINE DEVELOPER IN THE

  • BRAVO MAX ARE WUHAN VACCINE DEVELOPER IN THE EPICENTER

  • BRAVO MAX ARE WUHAN VACCINE DEVELOPER IN THE EPICENTER OF

  • DEVELOPER IN THE EPICENTER OF

  • DEVELOPER IN THE EPICENTER OF THE

  • DEVELOPER IN THE EPICENTER OF THE OUTBREAK.

  • THE OUTBREAK.

  • THE OUTBREAK. THEY4@

  • THE OUTBREAK. THEY4@ ENTERED

  • THE OUTBREAK. THEY4@ ENTERED AN

  • THE OUTBREAK. THEY4@ ENTERED AN AGREEMENT

  • THE OUTBREAK. THEY4@ ENTERED AN AGREEMENT TO

  • THEY4@ ENTERED AN AGREEMENT TO

  • THEY4@ ENTERED AN AGREEMENT TO CREATE

  • THEY4@ ENTERED AN AGREEMENT TO CREATE A

  • THEY4@ ENTERED AN AGREEMENT TO CREATE A VACCINE.

  • CREATE A VACCINE.

  • CREATE A VACCINE. >>

  • CREATE A VACCINE. >> THEY

  • CREATE A VACCINE. >> THEY HAVE

  • CREATE A VACCINE. >> THEY HAVE A

  • CREATE A VACCINE. >> THEY HAVE A STRONG

  • >> THEY HAVE A STRONG

  • >> THEY HAVE A STRONG RELATIONSHIP

  • >> THEY HAVE A STRONG RELATIONSHIP WITH

  • >> THEY HAVE A STRONG RELATIONSHIP WITH THE

  • >> THEY HAVE A STRONG RELATIONSHIP WITH THE CHINESE

  • RELATIONSHIP WITH THE CHINESE

  • RELATIONSHIP WITH THE CHINESE CDC

  • RELATIONSHIP WITH THE CHINESE CDC AND

  • RELATIONSHIP WITH THE CHINESE CDC AND THE

  • RELATIONSHIP WITH THE CHINESE CDC AND THE CHINESE

  • RELATIONSHIP WITH THE CHINESE CDC AND THE CHINESE PUBLIC

  • CDC AND THE CHINESE PUBLIC

  • CDC AND THE CHINESE PUBLIC REGULATORY

  • CDC AND THE CHINESE PUBLIC REGULATORY OFFICIALS.

  • REGULATORY OFFICIALS.

  • REGULATORY OFFICIALS. AND

  • REGULATORY OFFICIALS. AND WORKING

  • REGULATORY OFFICIALS. AND WORKING TOGETHER

  • REGULATORY OFFICIALS. AND WORKING TOGETHER WE

  • REGULATORY OFFICIALS. AND WORKING TOGETHER WE THINK

  • AND WORKING TOGETHER WE THINK

  • AND WORKING TOGETHER WE THINK WE

  • AND WORKING TOGETHER WE THINK WE CAN

  • AND WORKING TOGETHER WE THINK WE CAN MOVE

  • AND WORKING TOGETHER WE THINK WE CAN MOVE MUCH

  • AND WORKING TOGETHER WE THINK WE CAN MOVE MUCH QUICKER

  • AND WORKING TOGETHER WE THINK WE CAN MOVE MUCH QUICKER ALONG

  • WE CAN MOVE MUCH QUICKER ALONG

  • WE CAN MOVE MUCH QUICKER ALONG WITH

  • WE CAN MOVE MUCH QUICKER ALONG WITH THE

  • WE CAN MOVE MUCH QUICKER ALONG WITH THE OTHER

  • WE CAN MOVE MUCH QUICKER ALONG WITH THE OTHER ENTITIES

  • WE CAN MOVE MUCH QUICKER ALONG WITH THE OTHER ENTITIES WE

  • WITH THE OTHER ENTITIES WE

  • WITH THE OTHER ENTITIES WE BROUGHT

  • WITH THE OTHER ENTITIES WE BROUGHT IN

  • WITH THE OTHER ENTITIES WE BROUGHT IN WITH

  • WITH THE OTHER ENTITIES WE BROUGHT IN WITH A

  • WITH THE OTHER ENTITIES WE BROUGHT IN WITH A CANDIDATE

  • WITH THE OTHER ENTITIES WE BROUGHT IN WITH A CANDIDATE FOR

  • BROUGHT IN WITH A CANDIDATE FOR

  • BROUGHT IN WITH A CANDIDATE FOR TESTING.

  • TESTING.

  • TESTING. >>

  • TESTING. >> I'M

  • TESTING. >> I'M TOLD

  • TESTING. >> I'M TOLD THE

  • TESTING. >> I'M TOLD THE TIMELINE

  • TESTING. >> I'M TOLD THE TIMELINE FOR

  • >> I'M TOLD THE TIMELINE FOR

  • >> I'M TOLD THE TIMELINE FOR THE

  • >> I'M TOLD THE TIMELINE FOR THE VACCINE

  • >> I'M TOLD THE TIMELINE FOR THE VACCINE COULD

  • >> I'M TOLD THE TIMELINE FOR THE VACCINE COULD BE

  • >> I'M TOLD THE TIMELINE FOR THE VACCINE COULD BE READY.

  • THE VACCINE COULD BE READY.

  • THE VACCINE COULD BE READY. IT

  • THE VACCINE COULD BE READY. IT COULD

  • THE VACCINE COULD BE READY. IT COULD BE

  • THE VACCINE COULD BE READY. IT COULD BE MONTHS

  • THE VACCINE COULD BE READY. IT COULD BE MONTHS OR

  • THE VACCINE COULD BE READY. IT COULD BE MONTHS OR MORE

  • THE VACCINE COULD BE READY. IT COULD BE MONTHS OR MORE THAN

  • IT COULD BE MONTHS OR MORE THAN

  • IT COULD BE MONTHS OR MORE THAN 1

  • IT COULD BE MONTHS OR MORE THAN 1 YEAR.

  • IT COULD BE MONTHS OR MORE THAN 1 YEAR. 4@

  • 1 YEAR. 4@

  • 1 YEAR. 4@ THE

  • 1 YEAR. 4@ THE LARGEST

  • 1 YEAR. 4@ THE LARGEST UNKNOWN

  • 1 YEAR. 4@ THE LARGEST UNKNOWN IS

  • 1 YEAR. 4@ THE LARGEST UNKNOWN IS HOW

  • 1 YEAR. 4@ THE LARGEST UNKNOWN IS HOW LONG

  • THE LARGEST UNKNOWN IS HOW LONG

  • THE LARGEST UNKNOWN IS HOW LONG IT

  • THE LARGEST UNKNOWN IS HOW LONG IT WILL

  • THE LARGEST UNKNOWN IS HOW LONG IT WILL TAKE

  • THE LARGEST UNKNOWN IS HOW LONG IT WILL TAKE TO

  • THE LARGEST UNKNOWN IS HOW LONG IT WILL TAKE TO SEEK

  • THE LARGEST UNKNOWN IS HOW LONG IT WILL TAKE TO SEEK 4@4@GOVERN

  • IT WILL TAKE TO SEEK 4@4@GOVERN

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL TO

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL TO USE

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL TO USE THE

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL TO USE THE VACCINE

  • IT WILL TAKE TO SEEK 4@4@GOVERN APPROVAL TO USE THE VACCINE ON

  • APPROVAL TO USE THE VACCINE ON

  • APPROVAL TO USE THE VACCINE ON HUMANS.

  • HUMANS.

  • HUMANS. >>>

  • HUMANS. >>> THERE

  • HUMANS. >>> THERE ARE

  • HUMANS. >>> THERE ARE A

  • HUMANS. >>> THERE ARE A LOT

  • HUMANS. >>> THERE ARE A LOT OF

  • HUMANS. >>> THERE ARE A LOT OF STORIES

  • >>> THERE ARE A LOT OF STORIES

  • >>> THERE ARE A LOT OF STORIES CIRCULATING

  • >>> THERE ARE A LOT OF STORIES CIRCULATING ABOUT

  • >>> THERE ARE A LOT OF STORIES CIRCULATING ABOUT THE

  • CIRCULATING ABOUT THE

  • CIRCULATING ABOUT THE CORONAVIRUS

  • CIRCULATING ABOUT THE CORONAVIRUS AND

  • CIRCULATING ABOUT THE CORONAVIRUS AND MANY

  • CIRCULATING ABOUT THE CORONAVIRUS AND MANY ARE

  • CIRCULATING ABOUT THE CORONAVIRUS AND MANY ARE NOT

  • CORONAVIRUS AND MANY ARE NOT

RESOURCES

字幕と単語

ワンタップで英和辞典検索 単語をクリックすると、意味が表示されます